Our grant, entitled, “Hemodynamic Optimization and Preclinical Assessment of a Shape Memory Polymer Wrap to Reduce Hemodialysis Access Site Failures," will be in collaboration with a number of academic and medical institutions including Rice University, Houston Methodist Research Institute, Vanderbilt University, and the Yale School of Medicine.
End-stage renal disease and associated fistula failures affects hundreds of thousands of patients in the United States and costs Medicare billions of dollars each year. With this grant, we will be examining the hemodynamic affects of our SelfWrap on AV fistulas towards the goal of reducing access site failures for patients on dialysis.
Equally exciting and humbling, we are pleased to announce that we have closed our first priced equity round, led by Fort Worth-based Cowtown Angels, who also led our last round in March 2018. Thanks to their
We were able to open and close the round in roughly one week with the fantastic efforts of our friends and participants in our previous rounds, Cowtown Angels and the Texas HALO fund in Forth Worth and Houston, respectively.
These funds will be put towards further large animal work, biocompatability testing, manufacturing transfer, and other strategic efforts, looking forward to our eventual FDA approval.
We greatly appreciate all the faith that has been put in us and intend to be superior stewards of both taxpayer and investor money.
SelfWrap is currently in the research and development phase and is not available for sale in any country. Investigational Device. Limited by Federal Law to Investigational Use.© Copyright 2022 VenoStent, Inc.